In keeping with these results, an independent correlation of OPG levels with asymmetric dimethylarginine (ADMA), another biomarker of endothelial cell activation, has been disclosed in ankylosing spondylitis patients undergoing anti-TNF-α therapy [32]. This evidence concerns the gene TNF and ankylosing spondylitis.